We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
JAGSNPHARM.NSE

Price
202.45
Stock movement up
+2.02 (1.01%)
Company name
Jagsonpal Pharmaceuticals Limited
Exchange
(NSE
,
Currency
INR
)
Sector
Healthcare >
Drug Manufacturers - Specialty & Generic
Market cap
13.52B
Ent value
13.85B
Price/Sales
4.78
Price/Book
5.35
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
21.83
Forward P/E
-
PEG
-
EPS growth
46.90%
1 year return
-25.82%
3 year return
-
5 year return
-
10 year return
-
Last updated: 2025-12-12

DIVIDENDS

JAGSNPHARM.NSE does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E21.83
Price to OCF16.91
Price to FCF17.00
Price to EBITDA15.03
EV to EBITDA15.40

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales4.78
Price to Book5.35
EV to Sales4.90

FINANCIALS

Per share

Loading...
Per share data
Current share count66.78M
EPS (TTM)-
FCF per share (TTM)-

Income statement

Loading...
Income statement data
Revenue (TTM)-
Gross profit (TTM)-
Operating income (TTM)-
Net income (TTM)-
EPS (TTM)-
EPS (1y forward)-

Margins

Loading...
Margins data
Gross margin (TTM)-
Operating margin (TTM)-
Profit margin (TTM)-

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash127.93M
Net receivables225.66M
Total current assets2.02B
Goodwill96.93M
Intangible assets720.83M
Property, plant and equipment81.86M
Total assets2.99B
Accounts payable129.70M
Short/Current long term debt88.36M
Total current liabilities332.68M
Total liabilities461.88M
Shareholder's equity2.53B
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-
Capital expenditures (TTM)-
Free cash flow (TTM)-
Dividends paid (TTM)-

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-
Return on Assets-
Return on Invested Capital-
Cash Return on Invested Capital-

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open201.15
Daily high204.26
Daily low200.58
Daily Volume25K
All-time high304.48
1y analyst estimate-
Beta-0.24
EPS (TTM)-
Dividend per share0.00
Ex-div date12 Sep 2025
Next earnings date20 Jan 2026

Downside potential

Loading...
Downside potential data
JAGSNPHARM.NSES&P500
Current price drop from All-time high-33.51%-1.08%
Highest price drop-35.41%-19.00%
Date of highest drop25 Nov 20258 Apr 2025
Avg drop from high-21.19%-2.64%
Avg time to new high30 days6 days
Max time to new high259 days89 days
COMPANY DETAILS
JAGSNPHARM.NSE (Jagsonpal Pharmaceuticals Limited) company logo
Marketcap
13.52B
Marketcap category
Large-cap
Description
Jagsonpal Pharmaceuticals Limited engages in the manufacturing, selling, and trading of pharmaceutical products and active pharmaceutical ingredients in India and internationally. It offers pharmaceutical formulations and products in the areas of gynaecology, orthopaedics, dermatology, and paediatrics. The company provides drugs in the form of tablets, softgels, injections, capsules, and syrups. Jagsonpal Pharmaceuticals Limited was incorporated in 1978 and is based in Gurugram, India.
Employees
1399
Investor relations
-
CEO
Country
India
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found